失血性休克复苏液体的演进——低效价抗体O型全血正重新成为首选的应急通用桥接复苏液体
Evolution of resuscitation fluid for hemorrhagic shock——low titer group O whole blood is becoming preferred e-mergent universal bridging resuscitation fluid
王鸿捷 1郭永建2
作者信息
- 1. 北京市红十字血液中心,北京 100083;国家卫生健康标准委员会血液标准专业委员会
- 2. 国家卫生健康标准委员会血液标准专业委员会;福建省血液中心
- 折叠
摘要
血液复苏是严重失血患者的关键急救措施.血液复苏液体的选用,经历了从全血到晶体液/胶体液、晶体液联合红细胞、等比例血液成分的演进过程.近 20 年来,采用低效价抗体O型全血(low titer group O whole blood,LTOWB)作为血液复苏的首选应急通用桥接复苏液,已发展成为大趋势.我们对全血在严重失血患者的应用历史和现状做一介绍,并提出我国采用LTOWB作为首选应急通用血液的进一步论证和验证研究建议.
Abstract
Timely and effective blood resuscitation is very important for patients with severe blood loss.The resuscitation fluids for hemorrhagic shock have evolved from whole blood to crystalloid/colloid solutions,crystalloid combined with red blood cells,to balanced blood components.In the past 20 years,it is a growing trend that low titer antibody group O whole blood(LTOWB)is used as the preferred universal bridging resuscitation fluid for emergent blood resuscitation.Herein we provide a review of the history and current status of whole blood for patients with severe bleeding and make a suggestion to launch a national implementation research program of LTOWB in China.
关键词
低效价抗体O型全血/血液复苏/严重失血Key words
low titer group O whole blood(LTOWB)/resuscitation/hemorrhagic shock引用本文复制引用
出版年
2024
国家科技期刊平台
NSTL
万方数据